Huma receives regulatory approval to expand the number of patients manageable through its SaMD (Software as a Medical Device)

Huma receives U.S. Food and Drug Administration (FDA) Class II for its Software as a Medical Device (SaMD) platform. This clearance marks a significant milestone in patient monitoring and disease management.